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Abbreviation 
ASMD: absolute standardised mean difference 
ART: Arterial Revascularization trial.   
ATE: average treatment effect on the population  
BIMA bilateral internal mammary artery 
CABG: coronary artery bypass grafting  
ESS: Effective sample size 
IMA: internal mammary artery 
SIMA: single internal mammary artery  
S: skeletonized  
P: pedicled  
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Structured Abstract 
Objective(s): The question of whether skeletonized internal mammary artery (IMA) 
harvesting reduces the incidence of sternal wound complications in comparison to the 
pedicled technique, in the context of single or bilateral IMAs, remains controversial. 
We studied the impact IMA harvesting strategy on sternal wound complication in the 
Arterial Revascularization Trial (ART).  
Methods: Patients enrolled in the ART (n=3102) were randomised to coronary artery 
bypass grafting with single or bilateral IMAs. Sternal wound complication rates were 
examined according to the harvesting technique that was documented in 2056 
patients. The IMA harvesting technique, based on surgeon preference, resulted in 4 
groups: pedicled single IMA (P-SIMA, n=607), pedicled bilateral IMA (P-BIMA, n=459), 
skeletonized single IMA (S-SIMA, n=512) and skeletonized bilateral IMA (S-BIMA, 
n=478). Propensity Scores weighting was used to estimate the impact of the 
harvesting technique on sternal wound complications.  
Results: A total of 219 of 2056 patients (10.6%) experienced a sternal wound 
complication within 1 year from the index operation.  Of those, only 25 (1.2%) patients 
required sternal wound reconstruction. P-BIMA (OR 1.80; 95%CI 1.23 to 2.63) but not 
S-BIMA (OR 1.00; 95%CI 0.65 to 1.53) or S-SIMA (OR 0.89; 95%CI 0.57-1.38) was 
associated with a significantly increased risk of any sternal wound complications 
compared to P-SIMA.    
Conclusions: The present ART sub-study suggests that, with a skeletonization 
technique, the risk of sternal wound complication with BIMA grafting is at a 
similar level to that after standard pedicled SIMA harvesting whilst skeletonized 
SIMA harvesting did not add any further benefit when compared to pedicled 
SIMA harvesting.     
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Central picture: Incidence of sternal wound complications according to internal 
mammary artery harvesting strategies (P-SIMA: pedicled single internal mammary 
artery; P-BIMA: pedicled bilateral internal mammary arteries; S-SIMA: skeletonized 
SIMA; S-BIMA: skeletonized bilateral internal mammary arteries)  
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Central message  
In the Arterial Revascularization Trial, the risk of sternal wound complication with 
bilateral internal mammary arteries was comparable to that after single pedicled 
harvesting.  
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Perspective Statement 
By using a skeletonized harvesting technique, the risk of sternal wound complication 
with bilateral internal mammary artery (IMA) grafting is at a similar level to that after 
standard pedicled single IMA harvesting also in patients at higher risk such as insulin 
dependent diabetes, females and those with increased body mass index.   
Bilateral IMAs should not be denied on the basis of an increased risk of sternal wound 
complication if sketetonized harvesting technique is used.   
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The long term patency of conduits is one of the most important determinants of long-
term outcomes in coronary artery bypass grafting (CABG). The left internal mammary 
artery (IMA) is unanimously acknowledged as the best coronary conduit [1]. Although 
the right IMA has identical function and patency rates to the left IMA and despite 
accumulation of evidence on long term benefit by using bilateral IMAs (BIMA) over the 
past 20 years [2-4], the right IMA remains largely underutilized [5] mainly due to 
concerns over the potential for sternal wound complications [6]. 
There are two established techniques for harvesting the IMA: pedicled and 
skeletonized. Harvesting the IMA(s) in a pedicled fashion can potentially lead to 
significant sternal devascularisation [7,8]. As opposed to pedicled harvesting, 
minimization of tissue mobilization during skeletonized IMA harvesting has been 
shown to preserve substantial collateral flow to the sternum by sparing some of the 
sternal and intercostal branches that arise from the internal mammary artery as a 
common trunk [7,8]. This finding may have potential clinical significance with respect 
to reducing the risk of sternal wound complications by improving wound healing and, 
in particular, when both left and right IMAs are used [9].  
However, the magnitude of the potential clinical benefit from skeletonized over 
pedicled IMA harvesting on sternal wound complications still remains to be determined 
[10,11]. Moreover, skeletonized IMA harvesting is a more technically demanding and 
time consuming technique and concerns remain over a perceived increased risk of 
injury to the IMAs during skeletonization that may affect early outcomes [12]. 
Consequently, in the absence of a general consensus, pedicled IMA harvesting, 
remains the generally preferred approach worldwide. 
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The Arterial Revascularization Trial (ART) is a randomized comparison of bilateral IMA 
(BIMA) versus single IMA (SIMA) grafting in CABG surgery [13] and is also one of the 
largest studies of contemporary CABG with a high proportion of patients undergoing 
skeletonized IMA harvesting. We studied the impact of IMA harvesting strategy on 
sternal wound complication by conducting an analysis of data collected prospectively 
in the Arterial Revascularization Trial (ART).  
Methods 
This research adheres to the principles set forth in the Declaration of Helsinki 
(http://www.wma.net/en/30publications/10policies/b3/index.html). The ART has been 
approved by the institutional review board of all participating centers and informed 
consent was obtained from each participant. The protocol for ART has been published 
[14].  Briefly, ART is a two-arm, randomized multicentre trial, conducted in 28 hospitals 
in seven countries, with patients being randomized equally to SIMA or BIMA grafts. 
Eligible patients were those with multivessel coronary artery disease (including urgent 
patients but not evolving myocardial infarction) undergoing CABG, whereas those 
requiring single grafts or redo CABG were excluded. Only surgeons with experience 
of ≥50 BIMA operations were able to participate in the trial; standard methods for 
anaesthesia and myocardial protection were used according to local practice. For the 
purpose of the present analysis, patients were classified according to the “as 
treated” principle in the following groups: pedicled single IMA (P-SIMA), 
skeletonized single IMA (S-SIMA), pedicled bilateral IMA (P-BIMA) and 
skeletonized BIMA (S-BIMA). IMA harvesting technique was based on surgeon 
preference. This information was not recorded from the outset of the trial. Thus only 
2056 out of 3102 patients were included in the analyses; among those 1022 and 
1034 were initially allocated to BIMA and SIMA respectively. Crossover rate from 
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BIMA to SIMA was 115/1022 (11.2%) and from SIMA to BIMA was 30/1034 (2.9%). 
Finally a total of 937 and 1119 patients received BIMA and SIMA respectively.  
Outcomes definition 
The primary end-point for these analyses was the incidence of any sternal wound 
complication within 1 year after the index procedure, which included a broad definition 
ranging from superficial sternal wound discharge to sternal wound reconstruction.  We 
also investigated the impact of IMA harvesting strategy on the incidence of severe 
sternal wound complications, defined as sternal wound infection requiring antibiotics 
and/or sternal wound reconstruction. Adverse events including sternal wound 
complications were adjudicated blind by a member of the Clinical Event Review 
Committee.   
Statistical analysis 
For baseline characteristics, variables are summarised as mean for continuous 
variables and percentage for categorical variables. The chi squared test was used to 
test unadjusted association between treatment variable and outcomes. Multiple 
imputation (m=3) was used to address missing data (165 patients). Rubin’s method 
[15] was used to combine results from each of m imputed data sets.   
Inverse probability of treatment weighting for modelling causal effects was 
used to for multiple treatments comparison [16]. One of the advantages of this 
technique over standard pairwise propensity matching is the possibility of 
simultaneous comparisons between multiple treatments. Moreover, all the 
individuals in the study can be used for the outcomes evaluation whilst a large 
number of subjects may not be used in a propensity matching in particular 
when the sample size of treatment and control groups are similar. A 
generalised boosted model was implemented to estimate multinomial propensity 
 10 
scores (PS) adjusting for 14 pre-treatment covariates, and the propensity score was 
assumed as the probability that an individual with pre-treatment characteristics X 
receives treatment t (twang R package).The average treatment effect on the 
population (ATE) was used to answer the question of how, on average, the outcome 
of interest would change if everyone in the population of interest had been assigned 
to a particular treatment relative to if they had all received another single treatment. 
To estimate the ATE, we gave treated patients weight wi = 1/(1 – p(xi)), where p(xi) is 
the propensity score, and reference patients wi = 1/p(xi). P-SIMA was considered as 
the reference group in all comparisons. The absolute standardised mean difference 
(ASMD) was used as a balance metric to summarize the difference between two 
univariate distributions of a single pre-treatment variable. A value ≥0.20 (20%) was 
considered as an indicator of imbalance [17]. Effective sample size (ESS) was 
calculated to account for the potential loss in precision from weighting [16]. We then 
estimated the treatment effect estimates with a weighted regression model that 
contained only a treatment indicator. In addition, a combination of propensity score 
weighting and covariate adjustment (double robust) was used to correct the effect of 
IMA harvesting technique for residual imbalance and to estimate the effect size of 
other covariates. Lastly, we estimated the treatment effect within subgroups 
according to the presence of diabetes on insulin, gender and body mass index ≥30. 
R version 3.1.2 (2014-10-31) was used for all statistical analysis. 
Results 
Study population 
Among 2056 patients included in the present analysis, 1022 and 1034 were 
initially allocated to BIMA and SIMA respectively. Crossover rate from BIMA to 
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SIMA was 115/1022 (11.2%) and from SIMA to BIMA was 30/1034 (2.9%). Finally 
a total of 937 and 1119 patients received BIMA and SIMA respectively. IMA 
harvesting groups compared were:  607 P-SIMA, 459 P-BIMA, 512 S-SIMA and 
478 S-BIMA. The second IMA was initially attempted to be harvested but not 
used in 15 BIMA to SIMA crossovers. Of those, 5 were skeletonized and 10 were 
pedicled. Reasons for the second IMA not to be used were: evidence of injury 
during harvesting (n=4, all pedicled), unsatisfactory flow (n=5, 3 skeletonized, 2 
pedicled) or unsatisfactory length or size (n=6, 2 skeletonized, 4 pedicled). 
Overall, rate of injured/unsatisfactory second IMA was 5/483(1.0%) by using 
skeletonized technique and 10(2.1%) by using pedicled technique (P=0.22).  
Among those 15 cases, only 1 patient who received pedicled harvesting, 
experienced a sternal wound complication. 
Distribution of pre-treatment variables among IMA harvesting technique groups 
Table 1 summarises the distribution of pre-treatment variables. Although the four 
groups were comparable for most of the pre-treatment variables, insulin dependent 
diabetes was more common in patients receiving S-BIMA than in patients receiving P-
BIMA. In addition more women received either skeletonized SIMA or BIMA. Finally off-
pump surgery was more frequently performed in S-SIMA and S-BIMA groups 
compared to pedicled groups.  
After multinomial propensity score estimation balance check showed that the groups 
were sufficiently similar (ASMDs <0.20) to support causal estimation of the treatment 
effects, although subjects receiving P-BIMA continued to have a slightly lower 
prevalence of diabetes on insulin.  
Incidence of sternal wound complications  
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A total of 219 out of 2056 patients (10.7%) experienced a sternal wound complication 
within 1 year from the index operation.  Of those, 75 (3.6%) patients had severe sternal 
wound complications including 50 (2.4%) with sternal wound infection requiring 
antibiotic therapy but not reconstruction and 25 (1.2%) who needed sternal wound 
reconstruction. Most sternal wound complications including those requiring 
reconstruction occurred during the first three months (Figure 1).  
Effect of harvesting technique on sternal wound complication 
Table 2 and Figure 2 show the incidence of any sternal wound complications according 
to IMA harvesting groups. P-BIMA patients had a higher incidence of any sternal 
wound complication compared to the other groups. There were too few severe wound 
complications to detect differences among the treatment groups. Table 3 summarises 
the effect of IMA harvesting technique on the incidence of any sternal wound 
complications. PS weighted analysis showed that P-BIMA but not S-BIMA was 
associated with a significantly increased risk (~2 times) of any sternal wound 
complications when compared to P-SIMA. On the other hand, S-SIMA did not provide 
any benefit on the incidence of any sternal wound complication when compared to P-
SIMA. When the analysis was restricted to severe sternal wound complications only 
we were unable to demonstrate any significant impact of P-BIMA (OR 1.60; 95%CI 
0.85-3.00), S-BIMA (OR 1.15;95%CI 0.58-2.28) and S-SIMA (OR 0.97; 95%CI 0.45-
2.07) when compared to P-SIMA.  
Subgroup analysis 
Subgroup analysis (Table 3) suggested that the detrimental effect of P-BIMA on the 
incidence of any sternal wound complication might be exaggerated in the presence of 
diabetes on insulin (OR 4.05; 95%CI 0.86-19.21) although this analysis was largely 
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underpowered due to the very small number of patients on insulin (n=118). Of note, 
P-BIMA remained significantly associated with a higher risk of any sternal wound 
complication in patients not diabetic (OR 1.84; 95%CI 1.18-2.85). Moreover P-BIMA 
significantly increased the risk of any sternal wound complication in both obese and 
non-obese patients.   
In the situation of a single IMA, skeletonized SIMA did not add any significant benefit 
in terms of sternal wound complication when compared to P-SIMA also among high 
risk subgroups.  
Independent risk factors for sternal wound complication  
In a double robust analysis (Table 4 and Table 5), P-BIMA but not S-BIMA remained 
independently associated with an increased risk of any sternal wound complication. 
Insulin dependent diabetes, female gender, and higher BMI were independent risk 
factors for any and severe sternal wound complications.    
Mortality within 30 days and at 1 year 
There were 31 (1.5%) deaths within 30 days and 55 (2.6%) deaths by 1 year follow-
up. Mortality at 30 day and 1 year was comparable among IMA harvesting groups 
(Table 2).  30 day mortality among patients with and without sternal wound 
reconstruction was 0/25 (0%) and 31/2031 (1.5%). At 1 year, total deaths among 
patients with and without sternal wound reconstruction were 3/25 (12%) and 52/2031  
(2.7%).  
Discussion 
Despite increasing evidence from observational studies of the long term survival 
benefit of a second IMA [2,3], it remains largely underutilised being used in 4.1% of 
CABG in the USA [5], and around 10% in the UK and Australia [18]. Concern about 
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sternal wound complication is one of the main reasons limiting the use of more than 
one IMA, as a severe sternal wound complication dramatically increases in-hospital 
mortality as well as the expense of hospital stay [6].  
The present post hoc analysis of the ART demonstrates that in the modern era of 
CABG surgery sternal wound complications still affect about 10% of patients. In 
particular, severe sternal wound infection requiring antibiotic therapy or sternal wound 
reconstruction still affects nearly 2% and 1% of the surgical population respectively. 
The anticipated impact of sternal wound complication on resource consumption and 
patient outcomes represents an important consideration in the utilisation of BIMA 
grafting and an argument in favour of skeletonized IMA over pedicled IMA harvesting.   
The main finding of the present analysis is that BIMA harvesting can be safely 
performed using the skeletonized technique without increasing the risk of sternal 
wound complications when compared to the standard approach using a pedicled 
SIMA. Furthermore, skeletonized BIMA harvesting does not seem to significantly 
increase the risk even in higher risk groups, such as diabetics on insulin, females and 
the obese (BMI≥30). On the other hand, pedicled BIMA was associated with a nearly 
2 fold increased risk of any sternal wound complication. The detrimental effect of 
pedicled BIMA harvesting on sternal wound complication was relevant not only in high 
risk cases such as those who were obese or who had insulin dependent diabetes but 
also in the lowest risk CABG population who were not diabetic or obese, whilst 
skeletonized BIMA harvesting did not significantly increase the risk of sternal wound 
complications.  
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On the other hand, in the context of a single IMA graft, there was no evidence of the 
superiority of skeletonized SIMA harvesting over pedicled SIMA harvesting in reducing 
the risk of sternal wound complications.  
Skeletonized harvesting has been proposed to minimise the risk of sternal wound 
complication by preserving sternal perfusion especially in the context of BIMA usage 
[6]. Kamiya et al. [7] showed better oxygen saturation and blood flow in the 
microcirculation of sternal tissue when using skeletonized rather than pedicled IMA.  
Similarly, Boodhwani et al. [8], using radionuclear perfusion scanning, demonstrated 
that sternal perfusion was greater after skeletonized rather than pedicled harvesting. 
However, whether skeletonized IMA harvesting should be considered the standard 
approach with BIMA grafting and whether this approach also provides a significant 
benefit in SIMA grafting still needs to be determined. The potential clinical superiority 
of skeletonized over pedicled harvesting on sternal wound complications has been 
addressed only in a few studies with conflicting results reported [10-11]. Studies 
published to date are remarkably underpowered to detect any clinical benefit on low 
rate events such as sternal wound complications [11]. Moreover, skeletonized 
harvesting is more technically demanding and time consuming and, in the absence of 
general consensus, pedicled harvesting still remains the preferred approach 
worldwide.  
ART is one of the largest studies of contemporary CABG with a high proportion of 
patients undergoing skeletonized IMA harvesting [13]. To our knowledge, the present 
study is the largest analysis on the impact of IMA harvesting performed to date. We 
found that skeletonization while performing BIMA was safe as it did not increase 
the risk of damage to the harvested IMA. In fact, the rate of an 
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injured/unsatisfactory second IMA was 1.0% by using a skeletonized technique 
and 2.1% by using a pedicled technique thus supporting previous reports [22]. 
Moreover, mortality rate at 30 days and 1 year was comparable among the two 
techniques. With regard to sternal wound complications, skeletonized BIMA 
harvesting did not increase its risk when compared to pedicled SIMA and subgroup 
analysis suggested a protective effect from skeletonized BIMA also among high risk 
subjects. On the other hand, pedicled BIMA grafts seemed to increase the risk of 
sternal wound complications also among low risk subgroups (ie not on insulin nor 
obese). We also found no evidence that skeletonized SIMA harvesting added any 
protective effect when compared to a pedicled SIMA.  
Limitations 
The present analysis has some limitations. Despite propensity score adjustment, the 
present analysis was unable to address hidden biases due to unobserved differences 
between treated and control patients before treatment.  The present study was 
underpowered to detect differences in severe sternal wound complications among 
groups and most of the sternal complications were clinically less relevant. 
Fortunately, the low incidence of severe sternal wound complications would have 
required a much larger number of patients for analysis. Nevertheless, the difference 
in the rate of severe wound problems between the two groups supports the intrinsic 
benefit of the skeletonized technique of artery harvesting in terms of severe sternal 
wound complications. Sparing of the communicating bifurcation of the internal 
mammary artery to the chest wall and preservation of pericardiacophrenic artery 
branch has been reported to minimize the risk of sternal wound complication in 
patients receiving pedicled BIMA [23]. In the present study we could not confirm 
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this hypothesis as data on technical aspects of harvesting technique were not 
reported.  
Conclusion  
In conclusion, the present ART sub-study suggests that, with a skeletonization 
technique, the risk of sternal wound complication with BIMA grafting is at a similar level 
to that after standard pedicled SIMA harvesting whilst skeletonized SIMA harvesting 
did not add any further benefit when compared to pedicled SIMA harvesting. 
Skeletonized BIMA harvesting seems to provide a protective effect also in those at 
higher risk such as insulin dependent diabetes, females and those with increased BMI.   
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Table 1. Distribution of pre-treatment variables (as mean or percentage)  before (unweighted) and after (weighted) propensity score  
ASMD: absolute standardised mean difference; SD= standard deviation for all patients; P-SIMA: pedicled single internal mammary artery; P-BIMA: 
pedicled bilateral internal mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral internal mammary arteries; ESS: effective 
sample size; BMI: body mass index; NYHA: New York Heart Association; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular 
disease; MI: myocardial infarction; LVEF: left ventricular ejection fraction  
 P-SIMA 
n=607 
S-SIMA 
n=512 
P-BIMA 
n=459 
S-BIMA 
n=478 
ASMD P P-SIMA 
ESS=550 
S-SIMA 
ESS =454 
P-BIMA 
ESS =429 
S-BIMA 
ESS =430 
ASMD P 
 Unweighted 
 
 Weighted 
 
 
Age, year (SD=9) 64 65 63 64 
0.23 <0.001 
64 64 64 64 
0.06 0.36 
Female  11% 19% 12% 14% 
0.22 <0.001 
12% 14% 13% 12% 
0.05 0.36 
BMI (SD=4) 28.29 28.17 28.30 28.38 
0.05 0.44 
28.24 28.28 28.31 28.24 
0.02 0.77 
Creatinine,mmol/l (SD=22) 97.91 100.00 98.23 98.30 
0.09 0.13 
97.83 98.97 98.36 98.43 
0.05 0.37 
NYHA III/IV  26% 19% 28% 22% 
0.20 <0.001 
24% 22% 24% 21% 
0.06 0.37 
Diabetes orally treated  19% 19% 19% 19% 
0.02 0.70 
18% 19% 19% 19% 
0.02 0.73 
Diabetes on insulin  5% 6% 3% 8% 
0.21 <0.001 
5% 6% 3% 6% 
0.13 0.02 
Smoker  12% 13% 14% 16% 
0.10 0.10 
13% 13% 13% 14% 
0.03 0.65 
COPD  7% 6% 9% 6% 
0.13 0.05 
7% 7% 7% 6% 
0.04 0.51 
PVD  9% 8% 7% 7% 
0.07 0.27 
7% 8% 7% 8% 
0.04 0.61 
Prior stroke   3% 4% 2% 3% 0.09 
0.16 
3% 3% 2% 3% 
0.09 0.10 
Prior MI  42% 44% 39% 35% 
0.19 <0.001 
41% 41% 42% 39% 
0.06 0.38 
LVEF <.50  28% 26% 23% 21% 
0.16 0.01 
26% 25% 25% 23% 
0.06 0.39 
Caucasian  91% 92% 88% 92% 
0.15 0.02 
91% 92% 91% 93% 
0.07 0.28 
On pump  56% 42% 52% 39% 
0.35 0.00 
49% 46% 48% 46% 
0.07 0.29 
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Table 2. Outcomes among treatment groups.  
 
 All SWC 
(n=219) 
Severe SWC 
(n=150) 
30 day 
mortality 
(n= 31) 
1 year 
mortality 
(n=55) 
  All  
(n=75) 
SWC requiring 
antibiotics 
(n=50) 
Sternal wound 
reconstruction 
(n=25) 
  
P-SIMA (n=607) 58 (9.5%) 20 (3.3 %) 14(2.3%) 6 (1.0%) 8 (1.3%) 13 (2.1%) 
S-SIMA (n=512) 41(8.0%) 14 (2.7 %) 12(2.3%) 2(0.4%) 8 (1.6%) 15 (2.9%) 
P-BIMA (n=459) 74 (16.1%) 24 (5.2 %) 17(3.7%) 7(1.5%) 7 (1.5%) 12 (2.6%) 
S-BIMA (n=478) 46(9.6%) 17 (3.7 %) 7(1.5%) 10(2.1%) 8 (1.7%) 15 (3.1%) 
       
2 tests P 
P-SIMA as reference 
      
S-SIMA 0.39 0.60 1 0.30 0.80 0.44 
P-BIMA 0.0014 0.12 0.19 0.57 0.79 0.68 
S-BIMA 1 0.86 0.37 0.20 0.62 0.33 
P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral internal mammary arteries; S-SIMA: skeletonized 
SIMA; S-BIMA: skeletonized bilateral internal mammary arteries; SWC: sternal wound complication 
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Table 3. Propensity Score weighted effect (OR[95%CI]) of internal mammary artery harvesting on sternal wound complication.   
Bold: P<0.05; OR: Odds ratio; CI: confidence interval; P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral 
internal mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral internal mammary arteries; BMI: Body Mass 
index 
 
 
  
 Overall 
 
 
Diabetes 
On insulin 
 
Diabetes 
Orally treated 
 
Not Diabetic 
 
 
Female 
 
 
Male 
 
 
BMI≥30 
 
BMI<30 
 
Comparison 
P-SIMA as ref 
N=2056 N=118 N=386 N=1552 N=283 N=1773 N=631 N=1425 
P-BIMA  
 
1.80            
[1.23-
2.63] 
4.05                 
[0.86-19.21] 
1.41 
[0.58-3.45] 
1.84              
[1.18-2.85] 
1.08           
[0.41-2.83] 
1.96            
[1.30-2.98] 
2.07        
[1.09-3.90] 
1.67           
[1.03-2.68] 
S-SIMA   
 
0.89              
[0.57-1.38] 
1.35                   
[0.29-6.15] 
1.25                  
[0.49-3.19] 
0.75               
[0.43-1.29] 
0.72             
[0.27-1.90] 
0.91            
[0.55-1.51] 
1.46          
[0.73-2.90] 
1.09           
[0.65-1.83] 
S-BIMA  
 
1.00             
[0.65-1.53] 
1.92                        
[0.48-7.73] 
1.54                  
[0.64-3.73] 
0.78                  
[0.46-1.34] 
1.59              
[0.65-3.91] 
0.86           
[0.52-1.42] 
0.83           
[0.39-1.80] 
0.59             
[0.32-1.09] 
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Table 4. Results of double robust Propensity Score-weighted analysis on the incidence 
of any sternal wound complication  
 OR 95%CILL 95%CI UL P 
P-BIMA vs P-SIMA 1.85 1.25 2.74 0.002 
S-SIMA vs P-SIMA 0.98 0.64 1.52 0.94 
S-BIMA vs P-SIMA 0.87 0.55 1.36 0.53 
Age† 1.00 0.99 1.02 0.77 
Female 1.58 1.07 2.34 0.02 
BMI† 1.08 1.04 1.13 <0.001 
Creatinine† 0.99 0.98 1.00 0.01 
NYHA III-IV 1.01 0.70 1.45 0.96 
Diabetes orally treated 1.20 0.82 1.74 0.34 
Diabetes on insulin 2.17 1.29 3.66 0.003 
Smoking 1.27 0.83 1.95 0.27 
COPD 1.23 0.70 2.18 0.47 
PVD 0.81 0.44 1.48 0.49 
Prior stroke 1.67 0.80 3.50 0.17 
Prior MI 0.94 0.68 1.30 0.70 
LVEF<.50 1.02 0.71 1.46 0.91 
Caucasian 1.09 0.79 1.50 0.59 
† used as continuous variable; Odds ratio; LLCI: confidence interval lower limit; CI UL: 
confidence interval upper limit 
P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral internal 
mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral 
internal mammary arteries; BMI: body mass index; NYHA: New York Heart 
Association; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular 
disease; MI: myocardial infarction; LVEF: left ventricular ejection fraction  
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Table 5. Results of double robust Propensity Score-weighted analysis on the 
incidence of severe sternal wound complication  
 OR 95%CI LL 95%CI UL P 
P-BIMA vs P-SIMA 1.61 0.85 3.07 0.15 
S-SIMA vs P-SIMA 1.14 0.56 2.31 0.71 
S-BIMA vs P-SIMA 0.92 0.43 1.98 0.82 
Age† 1.00 0.97 1.03 0.79 
Female 2.48 1.38 4.45 0.002 
BMI† 1.11 1.04 1.18 0.001 
Creatinine† 1.00 0.99 1.01 0.76 
NYHA III-IV 0.83 0.42 1.61 0.57 
Diabetes orally treated 1.78 1.00 3.16 0.049 
Diabetes on insulin 2.72 1.25 5.92 0.01 
Smoking 1.72 0.88 3.35 0.11 
COPD 2.08 0.97 4.46 0.06 
PVD 0.53 0.17 1.66 0.27 
Prior stroke 1.74 0.62 4.90 0.29 
Prior MI 0.92 0.54 1.59 0.77 
LVEF<.50 1.03 0.56 1.87 0.93 
Caucasian 1.26 0.73 2.18 0.40 
† used as continuous variable; Odds ratio; LLCI: confidence interval lower limit; CI UL: 
confidence interval upper limit 
P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral internal 
mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral 
internal mammary arteries; BMI: body mass index; NYHA: New York Heart 
Association; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular 
disease; MI: myocardial infarction; LVEF: left ventricular ejection fraction  
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Figure Legends 
Figure 1. Time from index operation to any and severe sternal wound complication  
Figure 2. Incidence of any sternal wound complication according to internal 
mammary artery harvesting strategies. (P-SIMA: pedicled single internal mammary 
artery; P-BIMA: pedicled bilateral internal mammary arteries; S-SIMA: skeletonized 
SIMA; S-BIMA: skeletonized bilateral internal mammary arteries) 
